Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-06-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司第三届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution by Shenzhen Pumen Technology Co., Ltd. It details the meeting date, attendance, and the approval of an adjustment to the 2022 stock option incentive plan, including the cancellation of a portion of stock options. The document includes voting results and references another announcement on the Shanghai Stock Exchange website for more details. The content is a meeting resolution announcement rather than a full report or financial statement. It does not contain financial statements or detailed financial analysis, nor is it a call transcript, audit report, or regulatory certification. It is not a report publication announcement since it contains substantive meeting resolution content. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-06-25 Chinese
深圳普门科技股份有限公司股东及董监高减持股份计划公告
Director's Dealing Classification · 95% confidence The document is a detailed announcement regarding a planned reduction in shareholdings by certain shareholders and senior management of Shenzhen Pumen Technology Co., Ltd. It includes specifics about the shareholders involved, the number and percentage of shares to be reduced, the methods and timing of the reduction, and compliance with relevant securities laws and regulations. The content focuses on shareholding changes by insiders and major shareholders, which aligns with the definition of Director's Dealing filings. The document is not a financial report, earnings release, or general regulatory filing but specifically reports on insider and shareholder share transactions. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length and detail support a high confidence in this classification.
2024-06-12 Chinese
深圳普门科技股份有限公司关于2022年股票期权激励计划首次授予股票期权第二个行权期自主行权实施公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Shenzhen Pumen Technology Co., Ltd. regarding the implementation of the second exercise period of the first grant of the 2022 stock option incentive plan. It includes specifics about the stock option plan approval, implementation, exercise conditions, exercise quantities, prices, and legal opinions. The document is an official announcement about the exercise of stock options, including details on the number of options exercised, exercise price adjustments, and compliance with regulatory requirements. It does not contain financial statements or quarterly/annual financial results but focuses on stock option incentive plan execution and related corporate governance matters. This fits the category of Capital/Financing Update (CAP), as it relates to company financing activities through stock option exercises and share issuance to incentive plan participants.
2024-06-03 Chinese
深圳普门科技股份有限公司监事会对2021年股票期权激励计划行权相关事项的核查意见
Board/Management Information Classification · 95% confidence The document is a supervisory board's verification opinion on the exercise of stock options under the 2021 stock option incentive plan. It discusses compliance with laws and regulations, the legitimacy of the exercise qualifications, and the approval of the exercise arrangement. This is a formal opinion related to stock option exercises, which is a form of director or management-related information rather than a full financial report or announcement. It does not contain financial statements or earnings data, nor is it a general regulatory filing or announcement of a report. The document is focused on management-level decisions and approvals regarding stock options, fitting best under Board/Management Information (MANG). The document length is short and specific, not a report or announcement of a report, so it is not RPA or RNS.
2024-06-03 Chinese
深圳普门科技股份有限公司关于2021年股票期权激励计划预留授予股票期权第二个行权期自主行权实施公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the implementation of the second exercise period of a stock option incentive plan for the year 2021 by Shenzhen Pumen Technology Co., Ltd. It includes specifics about the stock option grant, exercise conditions, approval by the board and supervisory committee, exercise price adjustments, and legal opinions. The document is not a full financial report but rather a regulatory announcement about stock option exercises and related corporate actions. It does not contain quarterly or annual financial statements or earnings highlights. It is not a report publication announcement since it contains substantive details about the stock option exercise event itself. The document fits best into the category of Regulatory Filings (RNS) as it is a formal regulatory announcement about stock option exercise implementation and related approvals.
2024-06-03 Chinese
深圳普门科技股份有限公司监事会对第三届监事会第六次会议相关事项的核查意见
Regulatory Filings Classification · 90% confidence The document is a supervisory board's verification opinion on matters related to the company's stock option incentive plans, including adjustments to exercise prices, cancellation of unexercised stock options, and confirmation of exercise qualifications. It references compliance with relevant laws and company regulations but does not contain financial statements or detailed financial data. The document is a formal opinion or verification report by the supervisory board rather than a full financial report or announcement of voting results. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a simple announcement or certification but a detailed supervisory opinion on management matters related to stock incentives. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for such compliance and supervisory opinions that do not fit other categories.
2024-06-03 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.